Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI PET/CT in psoriatic arthritis
NCT05686876Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Nov 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 68Ga-FAPI in psoriatic arthritis (PsA), sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic value at 3 months. Status: unknown.
02
Drugs
68Ga-FAPI
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT05686876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05686876.